BARRINGER LABORATORIES INC (CIK: 0000859463) EDGAR, Information, Filings... CompaniesBIO.Com

BARRINGER LABORATORIES INC

Mailing address
, , Delaware,
Phone
3032771687
State location
Colorado
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES
Filings
N/A

BARRINGER LABORATORIES INC (CIK: 0000859463) is an American company incorporated in the state of Colorado. Head office is located at 15000 WEST 6TH AVE, STE 300, GOLDEN, Colorado, 80401. Work in the industry 8734 - (CF Office: Office of Trade & Services) SERVICES-TESTING LABORATORIES. BARRINGER LABORATORIES INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by BARRINGER LABORATORIES INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001021890-00-000293 ( Act) Size: KB	Aug-11-2000	000-18241 693201
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950135-00-003675 ( Act) Size: KB	Jul-28-2000	005-40699 681235
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950135-00-003607 ( Act) Size: KB	Jul-21-2000	005-40699 676808
8-K	Document	Current report filing Acc-no: 0001021890-00-000261 ( Act) Size: KB	Jun-28-2000	000-18241 663673
10QSB	Document	Acc-no: 0001021890-00-000247 ( Act) Size: KB	Jun-13-2000	000-18241 654244
NT 10-Q/A	Document	Amendment to Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001021890-00-000213 ( Act) Size: KB	May-16-2000	000-18241 638104
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001021890-00-000205 ( Act) Size: KB	May-15-2000	000-18241 636164
10-K405	Document	Acc-no: 0001021890-00-000190 ( Act) Size: KB	May-15-2000	000-18241 630459
8-K	Document	Current report filing Acc-no: 0001021890-00-000156 ( Act) Size: KB	Apr-21-2000	000-18241 606164
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000950135-00-002144 ( Act) Size: KB	Apr-13-2000	005-40699 600567
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000912057-00-016567 ( Act) Size: KB	Apr-06-2000	005-40699 595249
8-K	Document	Current report filing Acc-no: 0001021890-00-000126 ( Act) Size: KB	Apr-03-2000	000-18241 591940
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001021890-00-000109 ( Act) Size: KB	Mar-30-2000	000-18241 586262
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000912057-00-010729 ( Act) Size: KB	Mar-09-2000	005-40699 564926
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001021890-00-000067 ( Act) Size: KB	Mar-03-2000	000-18241 560283
8-K	Document	Current report filing Acc-no: 0001021890-00-000066 ( Act) Size: KB	Mar-03-2000	000-18241 560236
8-K	Document	Current report filing Acc-no: 0001021890-00-000065 ( Act) Size: KB	Mar-03-2000	000-18241 560234
10QSB	Document	Acc-no: 0000912057-99-006231 ( Act) Size: KB	Nov-15-1999	000-18241 99756381
10QSB	Document	Acc-no: 0001047469-99-032467 ( Act) Size: KB	Aug-16-1999	000-18241 99692728
8-K	Document	Current report filing Acc-no: 0001047469-99-028436 ( Act) Size: KB	Jul-23-1999	000-18241 99669260

Recent 20 filings. View all BARRINGER LABORATORIES INC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

BARRINGER LABORATORIES INC overview
BARRINGER LABORATORIES INC job
BARRINGER LABORATORIES INC stock
BARRINGER LABORATORIES INC ownership
BARRINGER LABORATORIES INC CEO
BARRINGER LABORATORIES INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.